Related Experiment Videos

Recurrent very late stent thrombosis in a systemic lupus erythematous patient

Dong-Yob Lee1, Jong-Pil Park, Sung-Jun Ko

  • 1Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea.

Insights

Systemic lupus erythematosus (SLE) patients undergoing coronary artery stenting face stent thrombosis risks. This case highlights the rare occurrence of very late recurrent stent thrombosis, happening four times in one SLE patient.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Coronary artery disease (CAD) is a primary cause of mortality in patients with systemic lupus erythematosus (SLE).
  • Stent thrombosis is a known complication following percutaneous coronary intervention (PCI) in SLE patients, similar to the general population.
  • Very late stent thrombosis (VLST) is an uncommon event, particularly recurrent instances.

Purpose of the Study:

  • To report an extremely rare case of recurrent very late stent thrombosis (VLST) in a patient with systemic lupus erythematosus (SLE).
  • To underscore the potential for severe thrombotic complications in SLE patients post-coronary stenting.

Main Methods:

  • Case report detailing a patient with SLE who experienced multiple thrombotic events after coronary artery stenting.
  • Review of clinical history, interventional procedures, and outcomes related to stent thrombosis.

Main Results:

  • The patient, diagnosed with SLE, suffered four distinct episodes of very late stent thrombosis.
  • This represents an exceptionally rare clinical presentation of recurrent VLST in the context of SLE and coronary stenting.

Conclusions:

  • Patients with SLE may be at risk for recurrent and very late stent thrombosis, even after successful coronary stenting.
  • This case emphasizes the need for vigilant monitoring and potentially tailored antithrombotic strategies in SLE patients with coronary artery disease.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...